Once-daily single-inhaler versus twice-daily multiple-inhaler triple therapy in patients with COPD: lung function and health status results from two replicate randomized controlled trials

BACKGROUND: The comparative efficacy of inhaled corticosteroid/long-acting muscarinic antagonist/long-acting β(2)-agonist (ICS/LAMA/LABA) triple therapy administered via single or multiple inhalers in patients with chronic obstructive pulmonary disease (COPD) has not been evaluated comprehensively....

Descripción completa

Detalles Bibliográficos
Autores principales: Ferguson, Gary T., Brown, Nicola, Compton, Chris, Corbridge, Thomas C., Dorais, Kelly, Fogarty, Charles, Harvey, Catherine, Kaisermann, Morrys C., Lipson, David A., Martin, Neil, Sciurba, Frank, Stiegler, Marjorie, Zhu, Chang-Qing, Bernstein, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7257245/
https://www.ncbi.nlm.nih.gov/pubmed/32471423
http://dx.doi.org/10.1186/s12931-020-01360-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7257245/
https://www.ncbi.nlm.nih.gov/pubmed/32471423
http://dx.doi.org/10.1186/s12931-020-01360-w

Ejemplares similares